XOMA xoma.com Earnings per share growth rate in current year

XOMA Royalty generates revenue from royalties on promising medications while avoiding research and development costs. The percentage deviation of EPS from the previous year demonstrates profit dynamics, where -45.60 reflects the most recent value of the metric. The holding status shifts operational risks to partners, while the absence of production costs ensures high pricing power and independence from inflation.
Financial and market metric breakdowns for xoma.com (XOMA)

This indicator measures the annual growth rate of earnings per share, allowing investors to assess the actual efficiency of capital generation without quarterly distortions. By analyzing the annual EPS trend, one can confirm the resilience of XOMA, whose biomedical operations are protected by diplomatic neutrality and the humanitarian status of its products, which minimizes geopolitical risks and ensures the stability of the asset.